Fig. 4.

Validation of mTBI in relation to progressive disease and treatment outcome. (A) Increasing mTBI predicts progressive disease during the period (x-axis) in 16 patients receiving chemotherapy only. Red triangles indicate an increase in mTBI exceeding the cutoff (≥0.6%). Gray triangles indicate an increase in mTBI below the cutoff (≥0.6%), or no increase. Purple vertical lines indicate clinical progressive disease.

(B) Chemo validation group. Kaplan-Meier analysis of progression-free survival in patients with high pretreatment mTBI (≥1%) compared with patients with low pretreatment mTBI (<1%) in AGC. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)